Van Eck Associates Corp Novartis Ag Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Novartis Ag stock. As of the latest transaction made, Van Eck Associates Corp holds 327,614 shares of NVS stock, worth $34.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
327,614
Previous 310,713
5.44%
Holding current value
$34.3 Million
Previous $35.4 Million
10.05%
% of portfolio
0.04%
Previous 0.04%
Shares
31 transactions
Others Institutions Holding NVS
# of Institutions
1,430Shares Held
131MCall Options Held
1.12MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA12.2MShares$1.28 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.26 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$848 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$732 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$604 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $225B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...